APF#

Related by string. * * APF# NDA . APF# Phase *

Related by context. All words. (Click for frequent words.) 65 JAK inhibitor 65 alvimopan 65 PDE4 inhibitor 65 elotuzumab 64 T Pred 64 SILENOR TM 64 PLK1 SNALP 64 Anturol 64 MGCD# [001] 64 Troxatyl 63 Locteron ® 63 EMBEDA ™ 63 Dacogen injection 63 BLA submission 63 Omigard 63 Cinryze ™ 63 pseudobulbar affect PBA 63 liprotamase 63 Dyloject TM 63 Cleviprex TM clevidipine 63 MAP# 63 BEMA TM Fentanyl 63 TELINTRA 63 IMA# 62 oral prodrug 62 SinuNase TM 62 pralatrexate 62 teduglutide 62 NEBIDO 62 ZEGERID Capsules 62 torezolid phosphate 62 Ferumoxytol 62 oral ridaforolimus 62 QNEXA 62 nalbuphine ER 62 palifosfamide 62 Vilazodone 62 5 HT3 antagonist 62 PROVENGE sipuleucel T 62 MAA submission 62 IRX 2 62 NDA submission 62 IV APAP 62 GALNS 62 tezampanel 62 LibiGel ® 62 pomalidomide 62 ELADUR 62 AeroLEF TM 62 LEVADEX 62 Neurodex 62 Azedra 62 Fibrillex TM 62 rhThrombin 62 Androxal ® 62 NDA resubmission 62 Zerenex 62 Alocrest 61 pradefovir 61 Chemophase 61 Marqibo 61 TOCOSOL Paclitaxel 61 glufosfamide 61 ELACYT 61 ApoB SNALP 61 investigational humanized monoclonal antibody 61 pegloticase 61 TLK# 61 dirucotide 61 Anturol ® 61 CoFactor 61 Onalta 61 Menerba 61 Panzem R NCD 61 Cinryze 61 PROMACTA 61 Androxal TM 61 FOLOTYN ® 61 oxymorphone ER 61 ONSOLIS 61 BLA filing 61 Octreotide 61 OncoVEX GM CSF 61 phase IIb clinical 61 Inhalation Solution 61 Panzem 61 Acetavance 61 IND submission 61 KRN# 61 PS# [001] 61 Zingo TM 61 DepoDur TM 61 AzaSite Plus 61 Surfaxin LS 61 Corlux 61 intravenous acetaminophen 61 Androxal 61 PSMA ADC 61 selective androgen receptor modulator 61 PREOS 61 Phase 2a trial 61 Panzem R 61 PREOS R 61 CINV 61 cangrelor 61 Civacir 61 Icatibant 61 faropenem medoxomil 60 bicifadine 60 Phase Ib study 60 reslizumab 60 Azedra TM 60 Zenvia 60 PRT# 60 Tekturna HCT 60 otelixizumab 60 Azedra ™ 60 eltrombopag 60 SILENOR 60 Anturol TM 60 satraplatin 60 Orapred ODT 60 Proxinium TM 60 ALGRX 60 Nasulin 60 PEG SN# 60 MoxDuo IR 60 Traficet EN 60 KNS # 60 Cellegesic 60 DPX Survivac 60 indiplon capsules 60 Amrubicin 60 Exelbine 60 candidate Zenvia 60 Dasatinib 60 lesinurad 60 Picoplatin 60 RAPAFLO 60 Exherin TM 60 targeted radiotherapeutic 60 Chrysalin 60 sodium Injection 60 Dyloject 60 Bezielle 60 GLP toxicology studies 60 HCV protease inhibitor 60 opioid induced bowel dysfunction 60 Urocidin 60 orBec 60 Phase IIb trials 60 atacicept 60 overactive bladder AA# 60 OvaRex ® MAb 60 Phase IIb clinical trials 60 investigational monoclonal antibody 60 histamine dihydrochloride 60 TBC# 60 EFAPROXYN 60 RSD# 60 Torisel 60 Adlea 60 PDX pralatrexate 60 FACTIVE R gemifloxacin 60 Auxilium transmucosal film 60 dextofisopam 60 Frova ® 60 refractory gout 60 MNTX 60 aflibercept 60 registrational 60 CB2 selective receptor agonist 60 Phase III clinical 60 DAVANAT 60 LEP ETU 60 Cloretazine 60 Onco TCS 60 #D#C# 60 L MTP PE 60 BiovaxID TM 60 Aloxi injection 60 PhosLo 60 Onsolis 60 talactoferrin 60 Hyphanox 60 MAXY G# 60 AMR# 60 MAGE A3 ASCI 60 SinuNase ™ 60 ELND# 60 Edoxaban 60 teriflunomide 60 BEMA Granisetron 59 INCB# [001] 59 Sym# 59 NVA# 59 Genasense ® oblimersen 59 huC# DM4 59 Onrigin TM 59 TRANSDUR Sufentanil 59 MBP# [001] 59 Carfilzomib 59 Saforis 59 forodesine 59 CIMZIA ™ 59 PEG PAL 59 ALN PCS 59 DAVANAT R 59 lomitapide 59 INT# [002] 59 Relivar 59 TORISEL 59 Ixempra 59 balsalazide tablet 59 sorafenib tablets 59 Zelrix 59 Orathecin 59 docetaxel Taxotere R 59 Junovan 59 Phase 2b study 59 Amigal 59 PRISTIQ 59 SNT MC# 59 BAY #-# 59 dalbavancin 59 elagolix 59 GSK# [001] 59 Xcytrin R 59 Locteron 59 orBec R 59 investigational compound 59 velafermin 59 Cloretazine R VNP#M 59 TELCYTA 59 Rapaflo 59 pivotal Phase III 59 HspE7 59 Targretin 59 Ketotransdel 59 Nebido 59 Fodosine 59 Bicifadine 59 ISTODAX 59 granisetron 59 subcutaneous formulation 59 YONDELIS 59 MyVax R 59 Alpharadin 59 mapatumumab 59 mertansine 59 Stedivaze 59 Ozarelix 59 Veronate 59 Factor VIIa 59 Strativa 59 omacetaxine 59 Zenpep 59 SinuNase 59 Dapagliflozin 59 Polymer Microspheres 59 PEG Interferon lambda 59 Besivance 59 Frova R 59 EXPAREL ™ 59 Q#IR 59 Pruvel 59 CIMZIA TM 59 CCX# 59 JANUVIA 59 Vicinium TM 59 elacytarabine 59 OMAPRO 59 faropenem 59 Oral NKTR 59 vilazodone 59 ZEGERID Powder 59 Zemiva ™ 59 Aurexis 59 BEMA Buprenorphine 59 Telavancin 59 GATTEX 59 thymalfasin 59 cobiprostone 59 R#/MEM # 59 acyclovir Lauriad R 59 Talabostat 59 EMBEDA 59 forodesine hydrochloride 59 deforolimus 59 torsemide ER 59 voreloxin 59 TYGACIL 59 EXALGO 59 confirmatory Phase III 59 azelastine 59 registrational trial 59 YERVOY 59 EndoTAG TM -1 59 Velcade bortezomib 59 ZOLINZA 59 Rhucin ® 59 ASONEP 59 picoplatin 59 delayed onset CINV 59 Xenazine ® 59 linaclotide 59 celgosivir 59 Aganocide 59 IL# PE#QQR 58 JZP 58 containing granisetron 58 Plenaxis TM 58 PRX # 58 Archexin 58 LEUKINE 58 vernakalant 58 HuMax EGFr 58 sapacitabine 58 candidate REP# 58 BCX# 58 TRISENOX 58 Perifosine 58 PREGNANT Study 58 Shigamabs R 58 histone deacetylase HDAC inhibitor 58 Aztreonam 58 PSN# [002] 58 PXD# 58 Capesaris 58 zileuton CR 58 Nexavar ® 58 Tamibarotene 58 obatoclax 58 ofatumumab 58 rilonacept 58 Rhucin 58 Phenserine 58 Topical Interferon Alpha 2b 58 ONTAK 58 alvespimycin 58 Combunox 58 Atiprimod 58 octreotide acetate 58 Nanobody 58 IIa trial 58 BYDUREON 58 Soliris TM eculizumab 58 SILENOR ™ 58 Sulonex 58 liposomal formulation 58 Trofex 58 virus HCV protease inhibitor 58 RDEA# 58 NP2 Enkephalin 58 Urocidin TM 58 Synavive 58 THALOMID 58 MEK inhibitor RDEA# 58 NeuroSTAT ® 58 IoGen 58 Complete Response 58 FavId 58 aclidinium 58 CIP TRAMADOL ER 58 dextromethorphan quinidine 58 Voraxaze 58 CEQ# 58 REG1 58 maribavir 58 palonosetron 58 Relistor 58 rNAPc2 58 phase IIa clinical 58 Firazyr 58 investigational drug 58 Allovectin 7 r 58 seliciclib CYC# 58 Linjeta TM 58 MAXY alpha 58 GSK# [002] 58 Allovectin 7 R 58 candidate TNFerade biologic 58 Dextofisopam 58 Hematide ™ 58 Phase III clinical trials 58 Iluvien ® 58 Fludara 58 custirsen 58 Glufosfamide 58 Levoleucovorin 58 Oncaspar 58 Tezampanel 58 HQK 58 Cinryze TM 58 BRILINTA 58 6R BH4 58 Intermezzo R 58 Tarceva TM 58 methylnaltrexone 58 AQ4N 58 diarrhea predominant irritable 58 NUVIGIL 58 treat dysmenorrhea 58 Exalgo 58 ATryn R 58 AGGRASTAT R 58 Anthim 58 adipiplon 58 Ereska 58 CR# vcMMAE 58 Phase IIa clinical trials 58 ONCONASE 58 Lidoderm R 58 carfilzomib 58 Hycamtin 58 Mepact 58 cinacalcet HCl 58 Aflibercept 58 acute onset CINV 58 Solazed TM 58 Zenvia Phase III 58 Dacogen decitabine 58 TMC# [002] 58 RSD# oral 58 Cardio Vascu Grow 58 Virulizin R 58 morphine sulfate extended 58 HuLuc# 58 M Enoxaparin 58 ALN VSP 58 thrombin inhibitor 58 PNT# 58 Protexia ® 58 tolevamer 58 VALSTAR 58 AEG# 58 NitroMist TM 58 PrevOnco 58 Arcalyst 58 Neo Urinary Conduit 58 T DM1 58 REMOXY R 58 Genasense R oblimersen 58 anticancer compound 58 atrasentan 58 Pennsaid R 58 ZYFLO 58 Golimumab 58 HCD# [002] 58 fidaxomicin 58 Ostarine 58 sufentanil 58 CANCIDAS 58 URG# 58 FIRAZYR 58 Stavzor 58 Surfaxin 58 Proellex TM 58 SPRYCEL ® 58 FOLOTYN 58 triphendiol 58 Lung Rx 58 VEGF Trap 58 Lamictal ODT 58 ONCONASE R 58 L DOS# 58 Biologics License Application BLA 58 vosaroxin 58 pexiganan 58 DR Cysteamine 58 MOZOBIL 58 topically applied SEPA 58 Ambrisentan 58 TG# [003] 58 PEG INTRON 58 Shigamabs ® 58 apricitabine ATC 58 topical gel 58 Hectorol R 58 GATTEX TM 58 ionotropic glutamate receptor antagonists 58 Elagolix 58 eniluracil 58 Phenoptin 57 ularitide 57 Zyflo 57 Retacrit 57 Jevtana 57 Pradefovir 57 Vernakalant 57 QRxPharma 57 valopicitabine 57 CYCLOSET 57 cintredekin besudotox 57 Telaprevir 57 postoperative ileus 57 muscarinic receptor agonist 57 Xanafide 57 metaglidasen 57 bazedoxifene 57 EndoTAG TM 57 Phase 2a clinical trials 57 sNDA submission 57 phase IIb trial 57 gallium nitrate injection 57 tesmilifene 57 Phase IIb clinical 57 Phase 2b trial 57 Fentanyl TAIFUN R 57 Flutiform TM 57 tivozanib 57 Phase III Clinical Trial 57 Indaflex TM 57 Infergen R 57 RECOTHROM R 57 BEMA ™ 57 FACTIVE tablets 57 rindopepimut 57 BLP# Liposome Vaccine 57 ZADAXIN ® 57 Aryplase 57 CD# antibody [001] 57 prGCD 57 TREDAPTIVE 57 Aerosurf 57 Triolex 57 IV acetaminophen 57 Oral Suspension 57 motexafin gadolinium Injection 57 TYZEKA 57 Ketotransdel ® 57 RhuDex ® 57 Viramidine 57 Protexia R 57 tasocitinib 57 Prodarsan ® 57 XGEVA 57 AGGRASTAT ® 57 Zemiva TM 57 Zensana 57 Fortical R 57 BEMA Fentanyl 57 raxibacumab 57 severe gastroparesis 57 Viprinex 57 pharmacokinetic PK study 57 mifamurtide 57 OMNARIS HFA 57 Alvesco R 57 Unit Dose Budesonide 57 EVIZON TM squalamine lactate 57 LEVADEX TM 57 Ophena TM 57 midstage studies 57 Onrigin 57 Mipomersen 57 Reverset 57 Riquent 57 trastuzumab DM1 T DM1 57 synthetic retinoid 57 ORENCIA R 57 docetaxel Taxotere ® 57 Tekamlo 57 Neuradiab 57 ThGRF 57 desvenlafaxine 57 diabetic neuropathic pain 57 CYC# 57 Pirfenidone 57 NGX# 57 Silenor ® doxepin 57 telaprevir VX 57 MGCD# [002] 57 lucinactant 57 Imagify 57 IONSYS TM 57 Vivaglobin 57 OFIRMEV 57 ZK EPO 57 Rezular 57 PRADAXA 57 LE SN# 57 TNFerade 57 DexaSite 57 Onbrez Breezhaler 57 molecular imaging radiopharmaceutical 57 Excellarate 57 postoperative ileus POI 57 ACAPODENE TM 57 delivers fluocinolone acetonide FA 57 Tesetaxel 57 cannabinor 57 inhaled formulation 57 CINTREDEKIN BESUDOTOX 57 OHR/AVR# 57 Preos 57 OncoGel 57 lexidronam injection 57 Topotecan 57 HDAC Inhibitor 57 Phase Ib 57 cancer immunotherapies 57 Taxotere ® 57 trospium 57 EOquin 57 xanthine oxidase inhibitor 57 AERx iDMS 57 investigational pharmacologically unique 57 Genz # 57 Sulonex TM 57 Targretin capsules 57 Microplasmin 57 Phase IIa clinical 57 Elotuzumab 57 pertuzumab 57 Amoxicillin PULSYS 57 Adcirca 57 leading oral taxane 57 Argatroban 57 Alzhemed TM 57 ALN TTR# 57 Surfaxin lucinactant 57 OvaRex R 57 relapsed multiple myeloma 57 Bioral ® 57 docetaxel Taxotere 57 Glybera R 57 tanespimycin 57 CDP# 57 LY# [003] 57 paliperidone palmitate 57 BYETTA ® 57 LHRH antagonist 57 Kuvan TM sapropterin 57 oral taxane 57 candidate ridaforolimus 57 Emezine 57 antithrombotics 57 sNDA 57 Preotact 57 Goserelin 57 Clonicel 57 XP# XP# 57 preclinical toxicology 57 UPLYSO 57 Phase IIa trials 57 HZT 57 CRMD# 57 superficial bladder cancer 57 Actimmune R 57 AMRIX 57 AZILECT R 57 FLECTOR ® Patch 57 lapatinib Tykerb 57 Inhalation Aerosol 57 M6G 57 tafamidis 57 SPARLON 57 Duromist ™ 57 iloperidone 57 Phase 1b 57 Zensana TM 57 CORLUX 57 Proquin XR 57 APF# NDA 57 GLP1 agonist 57 confirmatory Phase 3 57 thalidomide Thalomid 57 Octreolin 57 VAPRISOL 57 Ticagrelor 57 SAPHRIS 57 balsalazide 57 Actimmune ® 57 sapacitabine CYC# 57 herpetic keratitis 57 Technosphere Insulin 57 Numax 57 Folotyn 57 HGS ETR1 57 INC# 57 Myocet 57 Phase 2b clinical 57 TKM ApoB 57 enzastaurin 57 pitavastatin 57 TEMODAL 56 candidate ATHX 56 Bifeprunox 56 Xinlay 56 HGS# 56 AzaSite Xtra 56 Enjuvia 56 Irinotecan 56 dasatinib 56 CHMP recommendation 56 ACAPODENE 56 Abiraterone acetate 56 DORIBAX 56 Oxytrex 56 ATryn ® 56 TRANSDUR Bupivacaine 56 ADX# 56 Gabapentin GR 56 Fx #A 56 Increlex R 56 Pertuzumab 56 SUTENT ® 56 intranasal formulation 56 Cethrin 56 ZEVALIN ® 56 Guanilib 56 VIAtab TM 56 exenatide 56 intravenous formulation 56 Ustekinumab 56 REMOXY 56 non metastatic osteosarcoma 56 iclaprim 56 Defibrotide 56 alfimeprase 56 Zenvia ™ 56 Ranexa 56 midstage trials 56 INCB# [002] 56 Bydureon 56 ATPace TM 56 octreotide implant 56 NXL# 56 Restanza 56 L Annamycin 56 Fibrin Pad 56 Phase III trials 56 sitaxsentan 56 regadenoson 56 treprostinil 56 Sular formulation 56 inhalation aerosol 56 Aclidinium 56 LE DT 56 Cintredekin Besudotox 56 aprepitant 56 PROVENGE 56 Bicalutamide 56 Clofarabine 56 Tasigna nilotinib 56 Pacira 56 lorvotuzumab mertansine 56 riociguat 56 Xibrom 56 paclitaxel Taxol ® 56 Teflaro 56 BENLYSTA 56 albinterferon alfa 2b 56 Liprotamase 56 pegfilgrastim 56 Romiplostim 56 axitinib 56 vandetanib 56 Aeroquin 56 DDP# 56 MyVax ® 56 Vidaza azacitidine 56 Indomethacin 56 avanafil 56 Trofex TM 56 Troxatyl TM 56 gabapentin enacarbil 56 IMPACT IMmunotherapy 56 Treximet 56 AVN# [001] 56 DU #b 56 perifosine 56 Methylnaltrexone 56 ABILIFY ® 56 PMA submission 56 Mitoxantrone 56 GRALISE 56 pegylated interferons 56 methylnaltrexone bromide 56 Pazopanib 56 Silodosin 56 SPIRIVA HandiHaler 56 Vaprisol 56 MGd 56 desvenlafaxine succinate 56 candidate epratuzumab 56 SEASONIQUE 56 Arixtra 56 DAVANAT ® 56 ONSOLIS TM 56 panitumumab Vectibix 56 L BLP# 56 Pivotal Phase III 56 CIP ISOTRETINOIN 56 Lidoderm ® 56 NanoCrystal technology 56 dronabinol 56 orBec R oral beclomethasone 56 QNEXA ® 56 vaginally administered lidocaine 56 Vandetanib 56 IV Busulfex 56 Marketing Authorization Application 56 Nabi HB Intravenous 56 cathepsin K inhibitor 56 LAF# 56 Ganciclovir 56 Personalized Immunotherapy 56 Ranexa R 56 AEGR 56 NDA Submission 56 CORT # 56 #I TM# 56 Emend 56 TRO# 56 Allovectin 7 56 vidofludimus 56 OMS#HP 56 oxybutynin ATD TM 56 BrachySil TM 56 Levadex 56 hylan GF 56 LHRH antagonists 56 Zuplenz 56 brentuximab vedotin 56 Aloxi 56 MEK Inhibitor 56 Combidex 56 Panitumumab 56 LIALDA 56 Aztreonam lysine 56 C1 INH 56 tipranavir 56 vorinostat 56 Palonosetron 56 Tanespimycin 56 ISENTRESS 56 Phase 2b 56 acetonide FA 56 mesylate tablets 56 Herceptin trastuzumab 56 Ruconest 56 FASLODEX 56 TriRima 56 Eltrombopag 56 Horizant 56 Ocrelizumab 56 eprotirome 56 Kamada AAT 56 Temsirolimus 56 Annamycin 56 Wellbutrin XL R 56 delayed CINV 56 canakinumab 56 FDA approvable letter 56 ASA# 56 Ceplene 56 interferon gamma 1b 56 Gencaro 56 EXPAREL TM 56 Noxafil 56 ELND-#/AZD-# 56 Genasense ® 56 TREANDA 56 ixabepilone 56 SUTENT 56 ridaforolimus 56 plasma kallikrein inhibitor 56 ARIKACE ™ 56 Relovair 56 mGluR5 negative 56 Ketotransdel TM 56 Aloxi Injection 56 Gliadel Wafer 56 ceftaroline 56 HER2 positive metastatic breast 56 Exalgo TM 56 orally bioavailable 56 Genitope Corporation 56 Phase 1a clinical 56 abiraterone acetate 56 midstage clinical 56 adecatumumab 56 ILUVIEN ® 56 SCH # 56 FDA Complete Response 56 Tyrima 56 ozarelix 56 LY# [002] 56 CAPHOSOL 56 candidates bavituximab 56 CaPre TM 56 sorafenib Nexavar 56 Triphendiol 56 Evamist TM 56 aflibercept VEGF Trap 56 Lubiprostone 56 Cloretazine ® 56 abatacept Orencia 56 ATL/TV# 56 Kynapid 56 Pegloticase 56 ganetespib 56 ONGLYZA ™ 56 ponatinib 56 NEBIDO R 56 PULSYS 56 Dalbavancin 56 HuMax CD4 56 Telatinib 56 Sanctura XR 56 BiTE antibody 56 casopitant 56 candidate deforolimus 56 ezogabine 56 markets HP Acthar 56 CCR5 antagonist 56 Trexima 56 Plicera 56 Azixa 56 Mycamine 56 proprietary transdermal patch 56 Onconase 56 opioid bowel dysfunction 56 IND enabling 56 visilizumab 56 Boceprevir 56 VIMOVO 56 Empatic 56 LEVADEX ™ 56 Afatinib 56 Virulizin ® 56 Biologics License Application 56 Cethromycin 56 Augment Injectable 56 inhaled liposomal ciprofloxacin 56 subcutaneously administered 56 MYDICAR 56 SERMs 56 PSN# [001] 56 Initiate Clinical Trial 56 amrubicin 56 PORxin TM platforms 56 Clolar ® 56 KRYSTEXXA 56 APTIVUS 56 Harbor BioSciences 56 ENTEREG ® 56 phase IIb 56 Prosaptide 56 naltrexone hydrochloride 56 PORxin TM 56 FUSILEV ® 56 Angiocept 56 ACTEMRA 56 AVINZA 56 PROCHYMAL 56 pazopanib 56 rasagiline tablets 56 sunitinib malate 56 BiovaxID 56 active comparator 56 febuxostat 56 opiate analgesic 56 BENICAR HCT 56 Intravenous Human 56 crofelemer 56 HRPC 56 Celacade TM technology 56 Simulect 56 Revlimid lenalidomide 56 gepirone ER 55 PHX# 55 ADVEXIN 55 LymphoStat B 55 Zemplar 55 PROVENGE ® 55 Sprycel dasatinib 55 Keppra R 55 Rotarix ® 55 lubiprostone 55 hormone LHRH antagonist 55 Huntexil 55 markets Gelclair R 55 octreotide 55 ARIXTRA R 55 AP# [003] 55 pemetrexed Alimta 55 ocrelizumab 55 Desmoteplase 55 Biological License Application 55 oral anticoagulant 55 Neulasta ® 55 VISICOL R 55 Entereg 55 investigational hepatitis B 55 opioid induced constipation 55 trastuzumab emtansine T DM1

Back to home page